FALLS CHURCH, Va., Oct. 17, 2018 /PRNewswire-PRWeb/ -- Clinical Trial Risk and Performance Management Summit
Nov. 14-15, 2018 – Princeton, NJ
Technology has made it easier to collect and report all manner of clinical trial performance metrics. But in that sea of data, are companies focusing on what will move their organization forward?
Clinical trial leaders in every biopharma company are struggling with these questions. Some are ahead of others, but few have mastered the art of turning metrics into process perfection.
Come to Princeton Nov. 14 and 15 for the first-ever Metrics Champion Consortium Summit. This will be an exclusive gathering of the top minds in trial performance metrics, spearheaded by MCC Executive Director Linda Sullivan. The keynote speaker will be Ken Getz, Associate Professor and Director, CSDD, Tufts University and Founder and Board Chair, CISCRP, clinical trials guru, founder of CenterWatch and an MCC partner.
Linda Sullivan and Ken Getz and the roster of experts will guide attendees through the issues that are top of mind in clinical trials metrics today:
Linda Martin, President and Founder, KMR Group will present on the Next Gen Benchmarking in Biopharma. Benchmarks have been a key component in effective R&D and clinical trial management across the Industry for decades. Recently, the Industry has embraced more complex and analytical approaches to drive performance improvements. These techniques, built on machine learning, modeling, and advanced statistical approaches move beyond the general benchmarks to develop more sophisticated measures, models, and capabilities. These new approaches unearth a number of optimizations, specifically in country and site selection for clinical trials.
The Clinical Trial Risk and Performance Management Summit is interactive. Attendees roll up their sleeves with speakers and fellow attendees as they tackle case studies that will bring clarity to the metrics process — and provide needed answers.
Who Will Benefit:
This event is designed for professionals from pharmaceutical, biotechnology and medical device companies; CROs; and other clinical service providers who have responsibilities in the following areas:
Conference Details Clinical Trial Risk and Performance Management Summit Presented by Metrics Champion Consortium a Division of CenterWatch Nov. 14-15, 2018 – Princeton, NJ http://www.fdanews.com/ctriskperformancemngmntsummit
Tuition: Early Bird Pricing: $1,597 (available until Oct. 17, 2018) Regular Pricing: $1,797 (after Oct. 17, 2018) Significant team discounts are available.
Easy Ways to Register Online: http://www.fdanews.com/ctriskperformancemngmntsummit By phone: 888-838-5578 or 703-538-7600
About MCC Leading the drug-development enterprise in the adoption and utilization of standardized metrics and benchmarks to drive performance improvement. Founded in 2006, MCC is the leading industry association dedicated to the development of standardized performance metrics to improve clinical trials. MCC provides the collaborative environment for biopharmaceutical and device sponsors, service providers and sites to improve clinical-trial development through use of MCC standardized performance metrics.
Subscribe to our Free Newsletters!